Synthesis of 6-Halo-Substituted Pericosine A and an Evaluation of Their Antitumor and Antiglycosidase Activities

Mar Drugs. 2022 Jun 30;20(7):438. doi: 10.3390/md20070438.

Abstract

The enantiomers of 6-fluoro-, 6-bromo-, and 6-iodopericosine A were synthesized. An efficient synthesis of both enantiomers of pericoxide via 6-bromopericosine A was also developed. These 6-halo-substituted pericosine A derivatives were evaluated in terms of their antitumor activity against three types of tumor cells (p388, L1210, and HL-60) and glycosidase inhibitory activity. The bromo- and iodo-congeners exhibited moderate antitumor activity similar to pericosine A against the three types of tumor cell lines studied. The fluorinated compound was less active than the others, including pericosine A. In the antitumor assay, no significant difference in potency between the enantiomers was observed for any of the halogenated compounds. Meanwhile, the (-)-6-fluoro- and (-)-6-bromo-congeners inhibited α-glucosidase to a greater extent than those of their corresponding (+)-enantiomers, whereas (+)-iodopericosine A showed increased activity when compared to its (-)-enantiomer.

Keywords: 6-halogenated pericosine A analogues; antitumor; enantiomer; glycosidase inhibition; pericoxide; synthesis.

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Shikimic Acid* / analogs & derivatives
  • Structure-Activity Relationship
  • alpha-Glucosidases

Substances

  • Antineoplastic Agents
  • methyl (3S,4S,5S,6S)-6-chloro-3,4,5-trihydroxy-1-cyclohexene-1-carboxylate
  • Shikimic Acid
  • alpha-Glucosidases

Grants and funding

This study received no external funding.